Medtronic (MDT) EPS (Basic) (2014 - 2026)

Medtronic (MDT) has 13 years of EPS (Basic) data on file, last reported at $0.98 in Q2 2026.

• For the quarter ending Q2 2026, EPS (Basic) rose 18.9% year-over-year to $0.98; the trailing twelve-month figure through Apr 2026 stood at $3.77 (up 3.44% YoY), and the FY2026 full-year result was $3.77, up 3.4% from the prior year.
• EPS (Basic) advanced to $0.98 in Q2 2026, from $0.9 in the prior quarter.
• In the past five years, EPS (Basic) ranged from a high of $1.11 in Q2 2022 to a low of $0.33 in Q4 2022.
• A 5-year average of $0.85 and a median of $0.9 in 2023 frame the typical range for EPS (Basic).
• Across the five-year window, EPS (Basic) plunged 66.5% in 2022 and jumped 108.82% in 2023, its largest moves.
• Tracing MDT's EPS (Basic) over 5 years: stood at $0.33 in 2022, then jumped by 108.82% to $0.68 in 2023, then soared by 45.51% to $1.0 in 2024, then increased by 8.17% to $1.08 in 2025, then slipped by 8.89% to $0.98 in 2026.
• Business Quant data shows MDT's EPS (Basic) at $0.98 in Q2 2026, $0.9 in Q1 2026, and $1.08 in Q4 2025.